Abstract Acid phosphatase (ACP 1 ) is a polymorphic enzyme that catalyzes the conversion of flavin-mononucleotide (FMN) to riboflavin and regulates the cellular concentration of flavin-adenine-dinucleotide (FAD) and, consequently, energy metabolism. Its activity is modulated by adenosine deaminase locus 1 (ADA 1 ) genotype. The aim of our work is to verify whether individuals with a high proportion of ACP 1 f-isozyme and carrying the ADA 1 *2 allele, displaying the highest phosphatase activity, may have a higher life expectancy.
catalyzes the conversion of FMN to riboflavin, thus regulating cellular FAD concentration, flavo-enzyme activity, and energy metabolism. As phosphotyrosine phosphatase, ACP 1 may modulate the glycolytic rate controlling insulinreceptor activities and Band 3 protein status.
ACP 1 shows three common codominant alleles, ACP 1 *A, ACP 1 *B and ACP 1 *C, with combinations defining six phenotypes characterized by different enzyme activity (in the order, AϽB/AϽ(B, C/A)ϽC/B). The ACP 1 C phenotype is very rare. It is present only in Caucasian people, and it displays the highest enzyme activity (Boivin and Galand 1986; Bottini et al. 2002; Fuchs et al. 1992; Spencer et al. 1964 ).
Low ACP 1 activity makes an individual more susceptible to allergic disorders, to Th1-immune diseases, to Type 1 diabetes and to Crohn's disease. It also lowers the age at onset (Յ6 years) of Type 1 diabetes. ACP 1 *A/*A and *B/*A genotypes are over-represented in children with idiopathic, generalized tonic/clonic seizures, suggesting a detrimental role of low-ACP 1 activity also in the central nervous system. The ACP 1 *A allele has the highest frequencies in the population of northern latitudes, and it has been associated with greater body size and with adaptation to cold stress. ACP 1 A and ACP 1 B/A phenotypes are also associated with severe body-mass increase in obese adult subjects, in obese diabetic pregnant women, and in normal children 2002a , 2002b GloriaBottini et al. 2007; Greene et al. 2000; Lucarini et al. 1990; Paggi et al. 1991) .
The ACP 1 gene expresses two isozymes (f and s) showing different concentrations among the six ACP 1 phenotypes. These isozymes are expressed simultaneously in many tissues, and they are characterized by different biological functions. ACP 1 f-isozyme is the main isozyme responsible for the total ACP 1 activity (Dissing and Svensmark 1990; Fujimoto et al. 1988; Stefani et al. 1993) . Because different effects on f-and s-isozyme activity result from the modulation of ACP 1 enzymatic activity, C, CA, and A phenotypes (characterized by lower concentrations of f-isozymes) could be more susceptible to damage by oxidative events compared with the other phenotypes. Notably, leiomyoma size is negatively correlated with ACP 1 f-isozyme concentrations regulating negatively the cell proliferation and growth of leiomyomas through the dephosphorylation of the platelet-derived growth factor receptor (Ammendola et al. 2009 ).
ADA 1 is a polymorphic enzyme catalyzing the irreversible deamination of adenosine to inosine. It is present in all mammalian tissues, and it is controlled by a locus on the long arm of chromosome 20 with two codominant alleles ADA 1 *1 and ADA 1 *2 with different associated enzymatic activities. The ADA 1 *1 allele displays 30% higher enzymatic activity than the ADA 1 *2 allele (Battistuzzi et al. 1974 ). Experimental studies have also shown that adenosine, acting by means of the adenosine-1 A1 receptor, increases insulin sensitivity in isolated adipocytes and decreases insulin sensitivity in isolated muscle fibers (Challis et al. 1992; Dunwiddie and Masino 2001; Vannucci et al. 1992) . Interest has been focused on a wide variety of effects produced by adenosine through the activation of cell-surface adenosine receptors (Richardson 1997; Xu et al. 1998; Yasuda et al. 2003) . The transient activation of adenosine receptors protects against damage following hypoxic or ischemic events in brain and in other excitable tissues, such as the heart. A variation in energy states, cardiac stress, or other stimuli induces the release of adenosine which, by its receptors, can lead to a more efficient balance between energy utilization and energy supply and can also protect cardiac cells at extreme-stress conditions .
ACP 1 enzyme activity is modulated by the ADA 1 genotype: The ACP 1 A, BA, CA and CB activity is lower in ADA 1 *2 carriers than in ADA 1 *1/*1 subjects (Lucarini et al. 1989) . A positive association of the genotype ACP1*A/*A and ADA 1 *2 allele with Type 1 diabetes and a negative correlation between the frequency of this gametic type with past malarial morbidity in Sardinia (Gloria- Bottini et al. 2010 ) have already been reported. Moreover, a significant association between ACP 1 and ADA 1 has been found in Caucasians living in Australia and in a Brazil (Engràcia et al. 1991) .
Because ACP 1 f-isozyme is the main isozyme responsible for ACP 1 activity modulated by ADA 1 , we tested whether the subjects with a high proportion of ACP 1 f-isozyme and carrying ADA 1 *2 allele have a higher life expectancy.
Materials and Methods
Subjects. Peripheral blood was obtained from 1,072 (569 females and 503 males) unrelated individuals, 18 to 106 years of age, randomly recruited from the same geographical area of Central Italy (Marche region) on the eastern side of the Apennines. The whole population studied consisted of Caucasian individuals that were descendants of an ancient pre-Roman-Italian population called the Piceni (Cavalli-Sforza et al. 1994) . The same donors provided information concerning their health conditions. No pathological condition existed (e.g., cancer, diabetes, heart diseases, hypertension, obesity, and chronic inflammatory diseases). The sample study was divided into three sex-specific age classes (the age classes of women are written in square bracket). The first age class was made up of men with ages Ͻ66 [Ͻ73], the second class of men with ages 66 to 88 [73 to 91], and the third class by men of ages Ͼ88 [Ͼ91]. These gender-specific age classes were defined according to demographic information, and they accounted for different survivals of men and women in the Italian population (Passarino et al. 2006) . The study protocol was approved by the Joint Ethical Committee (JEC) University of Camerino-Azienda ASUR Marche ZT-10 Camerino, in accordance with the Declaration of Helsinki in its revised edition and with international and local regulatory requirements.
Genotyping. Genomic DNA extraction was carried out from peripheral blood through a standardized salting-out method, and DNA was stored at Ϫ20°C for gene analysis.
ACP 1 and ADA 1 SNPs were genotyped according to RFLP-PCR methods previously published (Lazaruk 1995; Napolioni and Lucarini 2010) . For ACP 1 , all PCRs were set up in 30 L and 0.2 mol/L of both primers, 0.1 mmol/L dNTPs, 1.5 mmol/L MgCl 2 , 0.5 U of Taq polymerase (AmpliTaq, Applied Biosystem, Mannheim, Germany), 1X AmpliTaq buffer (PE), and 50 ng of DNA template. The amplification conditions consisted of an initial denaturation at 94°C for 2 min, followed by 35 cycles of 94°C for 45 s, 54°C for 45 s, 72°C for 45 s, and a final extension at 72°C for 5 min. The annealing temperature, extension time, and primer concentration for the 2-kb amplification product were 57°C, 120 s, and 0.1 mol/L, respectively. Oligonucleotides used for PCR amplification are reported in Table 1 . The CT transition at Codon 43 and the AG transition at Codon 105 generate a CfoI and a TaqI restriction site that, together, were used for PCR-based genotyping, respectively. A 341-bp segment spanning the entire Exons 3 and 4 was amplified with Primers 263 to 264 (Table 1) . A 299-bp segment that included Exon 6 was amplified with primers 267 and 268. Ten microliters of the 341-bp Exon 3 amplicon was fully cleaved by CfoI at 37°C for 1 h according to the manufacturer's instructions and then electrophoresed on 1.8% agarose gels. The digestion created two fragments of 255 and 86 bp for the ACP 1 *A and ACP 1 *B haplotypes, whereas the ACP 1 *C haplotype was not cut. Similarly, the 299-bp PCR product was digested by TaqI at 65°C for 1 h according to the manufacturer's instructions, generating two fragments of 100 and 199 bp for the ACP 1 *A haplotype but not for the *B and *C haplotypes.
Briefly, for ADA 1 , PCR was performed with primers flanking the 22GA polymorphic region-5'-GCCCGGCCCGTTAAGAAGAGC-3' as sense primer and 5'-GGTCAAGTCAGGGGCAGAAGCAGA-3' as antisense primer. The PCR products were digested with TaqI endonuclease for 90 min at 65°C, and the samples were electrophoresed in a 1.8% agarose gel. The ADA 1 22*A (ADA 1 *2) allele was identified by the lack of a TaqI restriction site. Table 2 shows the frequency of the ACP 1 genotypes in relation to the ADA 1 genotypes and classes of age in males and females separately. All age classes are in HWE. In both sexes, ACP 1 *A/*B and *B/*B-ADA 1 genotypes have a greater frequency in all age classes. Table 3 shows ACP 1 genotype f-and s-isozyme concentrations according to Dissing (1987 Dissing ( , 1993 . The data of Dissing are reported to clarify the procedure to obtain the data reported in Table 4 . Table 4 shows the concentration of ACP 1 f-isozymeϪADA 1 *2 allele along the three age classes studied. The mean value of the ACP 1 f-isozyme amount among the various ACP 1 ϪADA 1 *2 genotypes is reported for each class (in accordance to Dissing 1987 Dissing , 1993 . The table shows also the t test for differences between means. The concentration of ACP 1 f-isozymeϪADA 1 *2 allele in Class 3 subjects is higher than the one in Class 2 and Class 1, but, compared with Class 1, it does not reach statistical significance (P ϭ 0.053). The ACP 1 f-isozymeϪADA1*2 allele concentration of subjects in Class 1 is not different from that of subjects in Class 2, whereas the differences between the concentration in Class 3 and Class 2 and between Class 3 and Class 2 plus Class 1 are highly significant.
Results

Discussion
In Class 3 compared with Class 2, or to Class 2 plus Class 1, a significant excess of individuals displays a higher amount of ACP 1 f-isozymeϪADA 1 *2 allele (Table 4) . Boivin and Galand (1986) demonstrated that ACP 1 dephosphorylates the tyrosine residues of the erythrocyte membrane protein 3 (B3P). The phosphorylation of B3P tyrosines prevents the binding of several glycolytic enzymes, causing high glycolytic rates in erythrocytes (Harrison et al. 1991; Low et al. 1987) . Furthermore, Stefani et al. (1993) demonstrated that the phosphotyrosine of a synthetic peptide corresponding to the sequence 5-16 of the B3P is much more efficiently hydrolyzed by the ACP 1 f-isozyme than by the s-isozyme. Therefore, because the ACP 1 f-amount is strongly related to the ACP 1 activity (Dissing and Svensmark 1990; Stefani et al. 1993 ) and its activity is enhanced by ADA 1 *2 (Lucarini et al. 1989) , it is conceivable that this fact may result in a significant dephosphorylation of the tyrosine residue of B3P, slowing the glycolytic rates in erythrocytes. Therefore, this may affect the Krebs cycle, thus resulting in a lesser amount of metabolic calorie. Moreover, the highest ACP 1 activity can dephosphorylate the insulin receptor, counteracting the action of insulin and decreasing glucose utilization. 
